Oyagüez, Itziar http://orcid.org/0000-0002-3047-6152
Suárez, Carmen
López-Sendón, José Luis
González-Juanatey, José Ramón
de Andrés-Nogales, Fernando
Suárez, Jorge
Polanco, Carlos
Soto, Javier
Funding for this research was provided by:
BMS Spain
Article History
First Online: 31 October 2019
Compliance with Ethical Standards
:
: This project received unrestricted financial support from Pfizer and Bristol-Myers Squibb S.A.U. Funding to pay the open access publication charges for this article was provided by Pfizer and Bristol-Myers Squibb S.A.U.
: IO and FAN are employed at Pharmacoeconomics and Outcomes Research Iberia (PORIB), a consultant company that specializes in economic evaluation of health technologies and has received financial support from Bristol-Myers Squibb S.A.U. for the development of the present work. CS, JLLS and JRGJ have received an unrestricted grant, as members of an advisory board, to validate the model inputs. JSuarez and CP are full-time employees of Bristol-Myers Squibb S.A.U. JSoto is a full-time employee of Pfizer S.L.U.